Fortitude Family Office’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-90
Closed -$117 – 2703
2026
Q2
$117 Buy
+90
New +$124 ﹤0.01% 2161
2026
Q1
– Sell
-592
Closed -$1.31K – 1999
2025
Q4
$1.31K Buy
+592
New +$1.11K ﹤0.01% 1354
2025
Q3
– Sell
-271
Closed -$702 – 2074
2025
Q2
$702 Buy
+271
New +$1.07K ﹤0.01% 1658

Other funds holding LUNG

Fortitude Family Office's LUNG Position: Q3 2026 in Review

Fortitude Family Office sold out of Pulmonx (LUNG) in Q3 2026, closing a stake of 90 shares — an estimated $117 sold.

Fortitude Family Office first reported a position in LUNG in Q2 2025 and held it in 3 quarters. The position peaked at $1.31K in Q4 2025. 5 funds tracked by Wall St. Rank hold LUNG as of Q3 2026.

  • Fortitude Family Office reported no remaining Pulmonx position as of Q3 2026 after selling out during the quarter.
  • Fortitude Family Office sold 90 Pulmonx shares in Q3 2026, an estimated $117.
  • Fortitude Family Office first reported a position in Pulmonx in Q2 2025 and held it in 3 quarters.
  • Fortitude Family Office's Pulmonx position peaked at $1.31K in Q4 2025.
  • 5 funds tracked by Wall St. Rank held Pulmonx as of Q3 2026.

Based on Fortitude Family Office's 13F filing for Q3 2026, filed 14 Oct 2026.